Gene · 10657
Papers1,948
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,948
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regionally restricted modulation of Sam68 expression and Arhgef9 alternative splicing in the hippocampus of a murine model of multiple sclerosis. | Front Mol Neurosci | 2022 | 36710925 | PubTator, text mining | PubMed |
| Hsrω and Other lncRNAs in Neuronal Functions and Disorders in Drosophila. | Life (Basel) | 2022 | 36675966 | PubTator, text mining | PubMed |
| HAT- and HDAC-Targeted Protein Acetylation in the Occurrence and Treatment of Epilepsy. | Biomedicines | 2022 | 36672596 | PubTator, text mining | PubMed |
| To β or Not to β: How Important Is β-Catenin Dependent and Independent WNT Signaling in CLL? | Cancers (Basel) | 2022 | 36612190 | PubTator, text mining | PubMed |
| N6-methyladenosine (m6A) RNA modification in the pathophysiology of heart failure: a narrative review. | Cardiovasc Diagn Ther | 2022 | 36605077 | PubTator, text mining | PubMed |
| Interplay of four types of RNA modification writers revealed distinct tumor microenvironment and biological characteristics in pancreatic cancer. | Front Immunol | 2022 | 36601127 | PubTator, text mining | PubMed |
| SRC kinase-mediated signaling pathways and targeted therapies in breast cancer. | Breast Cancer Res | 2022 | 36581908 | PubTator, text mining | PubMed |
| SETD7 Expression Is Associated with Breast Cancer Survival Outcomes for Specific Molecular Subtypes: A Systematic Analysis of Publicly Available Datasets. | Cancers (Basel) | 2022 | 36551516 | PubTator, text mining | PubMed |
| Cdk1-mediated threonine phosphorylation of Sam68 modulates its RNA binding, alternative splicing activity and cellular functions. | Nucleic Acids Res | 2022 | 36537190 | PubTator, text mining | PubMed |
| The potential of PARP inhibitors in targeted cancer therapy and immunotherapy. | Front Mol Biosci | 2022 | 36533080 | PubTator, text mining | PubMed |
| Mutant Allele of CD44 (rs8193C>T) and Pum2 Regulatory Element as A Prognosis Factor of Prostate Neoplasms: A Case-Control and In Silico Studies. | Cell J | 2022 | 36527344 | PubTator, text mining | PubMed |
An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019: Implications for vascular and coagulation disease associated with severe acute respiratory syndrome coronavirus infection. | Front Microbiol | 2022 | 36519165 | PubTator, text mining | PubMed |
| Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy. | J Clin Med | 2022 | 36498571 | PubTator, text mining | PubMed |
| Differentially Expressed Cell Cycle Genes and STAT1/3-Driven Multiple Cancer Entanglement in Psoriasis, Coupled with Other Comorbidities. | Cells | 2022 | 36497125 | PubTator, text mining | PubMed |
| Characterization of protein isoform diversity in human umbilical vein endothelial cells via long-read proteogenomics. | RNA Biol | 2022 | 36457147 | PubTator, text mining | PubMed |
| Identifying novel interactions of the colon-cancer related APC protein with Wnt-pathway nuclear transcription factors. | Cancer Cell Int | 2022 | 36457029 | PubTator, text mining | PubMed |
| Proximity-dependent biotinylation technologies for mapping RNA-protein interactions in live cells. | Front Mol Biosci | 2022 | 36452457 | PubTator, text mining | PubMed |
| Tough Way In, Tough Way Out: The Complex Interplay of Host and Viral Factors in Nucleocytoplasmic Trafficking during HIV-1 Infection. | Viruses | 2022 | 36423112 | PubTator, text mining | PubMed |
| Identification of potentially functional modules and diagnostic genes related to amyotrophic lateral sclerosis based on the WGCNA and LASSO algorithms. | Sci Rep | 2022 | 36418457 | PubTator, text mining | PubMed |
| Phosphorylation of the smooth muscle master splicing regulator RBPMS regulates its splicing activity. | Nucleic Acids Res | 2022 | 36408906 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10657/papers?page=11